Important Information!! NABP 2013 Meeting PowerPoint Presentation on Compounding and other Hot Topics

- 4 PM Pre-Meeting CPE
The Compounding/Manufacturing Debate:
When Is a Duck Not a Duck?
ACPE #205-0000-13-001-L03-P
(0.2 CEUs – 2 contact hours)

• Sarah Sellers, MPH, PharmD, Senior Director, Epidemiology and Risk Management, Ther-Rx Corporation
  View Presentation (PDF)
• John Clay Kirtley, PharmD, Executive Director, Arkansas State Board of Pharmacy
  View Presentation  (PDF)
• Lloyd K. Jessen, JD, RPh, Iowa Board of Pharmacy and Member, NABP Executive Committee
  View Presentation (PDF)
  View FDA Inspection List (PDF)
  View Nonresident Pharmacies List (PDF)
  View News Article (PDF)

Sunday, May 19, 2013

3:30 - 4:30 PM
Joint CPE
gTLD and LegitScript Investigations Update
Sponsored by DaVita Rx
ACPE #205-0000-13-003-L03-P
(0.1 CEU – 1 contact hour)

• John Horton, JD, President, LegitScript
  View Presentation (PDF)

Monday, May 20, 2013

8:15 - 10:15 AM
Joint CPE
Veterinary Pharmacy Issues:
Identifying Illegal Practices and Distinguishing
Supply Chain Variations
Sponsored by Walgreen Co
ACPE #205-0000-13-004-L03-P
(0.2 CEUs – 2 contact hours)

• Thomas J. Cusick, DVM, Owner and Director, Watertown Animal Hospital
  View Presentation (PDF)
• Terry J. Crowder, MBA, PhD, RPh, Pharmacy Manager, The Corvallis Clinic
  View Presentation (PDF)
• Brian T. Bowers, PharmD, FSVHP, Associate Director, Pharmacy Services, Oregon State University College of Veterinary Medicine
  View Presentation (PDF)

Tuesday, May 21, 2013

8:45 - 10:15 AM
Executive Officer and
Board Member CPE
Virtual Pharmacy Practice and
Wholesale Distribution – Out of Thin Air
Sponsored by Teva Pharmaceuticals
ACPE #205-0000-13-005-L03-P
(0.15 CEUs – 1.5 contact hours)

• Virginia Herold, MS, Executive Officer, California State Board of Pharmacy
  View Presentation (PDF) 
• LCDR Eleni Anagnostiadis, RPh, Acting Director, Division of Supply Chain Integrity, Office of Drug Security, Integrity, and Recalls, Center for Drug Evaluation and Research, Food and Drug Administration
  Presentation not available
• John Roth, JD, Director, Office of Criminal Investigations, Food and Drug Administration
  Presentation not available

8:45 - 10:15 AM
Compliance Officer CPE
Pill Mills, Non-Therapeutic Drug Use,
and Prescription Drug Monitoring:
What to Look for During Investigations
ACPE #205-0000-13-006-L03-P
(0.15 CEUs – 1.5 contact hours)

• Kyle W. Parker, MBA, RPh, Executive Director, Ohio State Board of Pharmacy
  View Presentation (PDF)
• Jeffrey J. Mesaros, PharmD, JD, Member, Florida Board of Pharmacy
  View Presentation (PDF)

10:30 AM - noon
Joint CPE
Are Biosimilars the Same as Generics?
Point-Counterpoint
Sponsored by Walgreen Co
ACPE #205-0000-13-007-L03-P
(0.15 CEUs – 1.5 contact hours)

• Tina S. Morris, PhD, Vice President, Biologics and Biotechnology, Global Science and Standards Division, United States Pharmacopeial Convention
  View Presentation  (PDF)
• Gillian Woollett, MA, DPhil, Senior Vice President, Avalere Health, LLC
  View Presentation (PDF)